The U.S. Food and Drug Administration issued its first formal guidance on how to design and run clinical trials for ...

The FDA is slated to make a decision on the flu shot on Aug. 5, which will allow Moderna to make the vaccine available for ...

The FDA has accepted Moderna’s revised influenza vaccine filing days after controversially refusing to review the original submission, putting the biotech on track to win approval in time for the 2026 ...

Recent US drug pricing reforms adopt international prices shaped by quality-adjusted life-year (QALY)-based assessments, despite longstanding federal prohibitions on using QALYs in coverage and ...

NEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe ...

LAS VEGAS, NV, UNITED STATES, February 11, 2026 / EINPresswire.com / — Mentavi Health, a provider of evidence-based digital ...

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna ...

In a rare and surprising move, the FDA has issued a “Refusal to File” letter for Moderna’s mRNA-1010 influenza vaccine.

In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well as the impact on the company and others in the industry.

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...

Machine learning is helping neuroscientists organize vast quantities of cells’ genetic data in the latest neurobiological cartography effort.

Over on YouTube [Andrew Neal] has a Function Generator Build for Beginners. As beginner videos go this one is fairly ...